Status:
COMPLETED
PENS or TENS for Pain in Pancreatic Cancer
Lead Sponsor:
Fuda Cancer Hospital, Guangzhou
Conditions:
Pain
Cancer Pain
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
This study evaluates the effect of percutaneous electrical nerve stimulation (PENS) and transcutaneous nerve stimulation (TENS) for pain relieving in patients with pancreatic cancer. Patients will ran...
Detailed Description
PENS and TENS have been reported with analgesic effect in patients with pain, including cancer pain, lower back pain, neck pain, stomachache and so on. Effect and mechanism of PENS on pain relieving ...
Eligibility Criteria
Inclusion
- Pancreatic cancer with pain;
- Haven't underwent neurolytic celiac plexus block in the past 1 month;
- With anticipatory survival of more than 3 months.
Exclusion
- Metastatic pancreatic cancer;
- Can not tolerate 30 min of lieing in prostrate or side position;
- PS\>3;
- Who has been recruited in other clinical trial for pain releiving;
- Who underwent radiotherapy or local radiactive seeds implantation for pain releiving in the past month;
- Imaging diagnosed with encephalic tumor or metastasis;
- Who with cardiac pacemaker or metal stand;
Key Trial Info
Start Date :
October 27 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 26 2019
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT03331055
Start Date
October 27 2017
End Date
August 26 2019
Last Update
September 12 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fuda Cancer Hospital
Guangzhou, Guangdong, China, 510665